Azzad Asset Management Inc /Adv Halozyme Therapeutics, Inc. Transaction History
Azzad Asset Management Inc /Adv
- $1.01 Trillion
- Q3 2025
A detailed history of Azzad Asset Management Inc /Adv transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 11,930 shares of HALO stock, worth $811,836. This represents 0.09% of its overall portfolio holdings.
Number of Shares
11,930Holding current value
$811,836% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
635Shares Held
128MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.2 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$833 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$404 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$236 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$231 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.48B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...